<p>Preclinical results demonstrate safe and efficient immune response with vaccine development showing promise of neutralizing activity for a range of variants LAWRENCEVILLE, N.J., Jan. 31, 2022
<ul><li>Prior 1.75%</li><li>Significant tightening of policy in recent quarters is countering remaining inflationary pressure</li><li>It cannot be ruled out that fu
Leave a Comment